JULIE OJA: Open Payments
NPI 1548365166 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 131 payments from 16 companies in 2025. Trend: 2023 $1,713 · 2024 $2,020 · 2025 $1,842
Food & beverage: $1,767Education: $76
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $313 |
| Teva Pharmaceuticals USA, Inc. | 18 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $238 |
| Alkermes, Inc. | 11 | $226 |
| Neurocrine BioSciences, Inc. | 18 | $205 |
| Otsuka America Pharmaceutical, Inc. | 11 | $181 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $75 |
| E.R. Squibb & Sons, L.L.C. | 4 | $58 |
| Novo Nordisk Inc | 3 | $48 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, INGREZZA, REXULTI, AUSTEDO XR, FANAPT, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
